Shaoli Song
Leads the nuclear medicine group behind the first human TROP2 PET imaging, aiming to pick patients for TROP2 ADCs with a scan.
Overview
Shaoli Song is Professor and Director of the Department of Nuclear Medicine at Fudan University Shanghai Cancer Center. Her department developed and imaged the first TROP2-targeted PET tracers in patients with breast and other cancers, with the aim of selecting patients for TROP2 antibody-drug conjugates using a scan, alongside FAPI, HER2 and PSMA theranostic work. Her publications include head-to-head comparisons of FDG and FAPI PET-CT in recurrent soft tissue sarcoma and in platinum-sensitive recurrent ovarian cancer, and a study of preoperative FDG PET parameters for predicting microvascular invasion and recurrence in hepatocellular carcinoma. Her interests are PET tracer development and theranostics.
| Title | Journal | Year |
|---|---|---|
| Head-to-head evaluation of [18F]FDG and [68 Ga]Ga-DOTA-FAPI-04 PET/CT in recurrent soft tissue sarcoma | European Journal of Nuclear Medicine and Molecular Imaging | 2022 |
| Head-to-head comparison of [18F]-FDG and [68 Ga]-DOTA-FAPI-04 PET/CT for radiological evaluation of platinum-sensitive recurrent ovarian cancer | European Journal of Nuclear Medicine and Molecular Imaging | 2023 |
| The value of preoperative 18F-FDG PET metabolic and volumetric parameters in predicting microvascular invasion and postoperative recurrence of hepatocellular carcinoma | Nuclear Medicine Communications | 2021 |
Similar pages
not linked directly; found by shared links- IdeaFAPI PET as the workup for MCED positives
- IdeaTROP2 PET to choose and sequence TROP2 ADCs
- OpportunityTROP2 imaging where no tissue test is required
- IndicationTriple-negative breast cancer
- RoadmapMolecular imaging roadmap: FDG → PSMA → FAP → antigen and immune PET
- IdeaAlpha radioligands after ADC failure
- IndicationPancreatic ductal adenocarcinoma
- IdeaFAP-targeted radioligand therapy for sarcoma